Atezolizumab trials for Small Cell Lung Cancer Extensive Stage

All Atezolizumab trials · All Small Cell Lung Cancer Extensive Stage trials

Phase breakdown

Recruiting trials studying Atezolizumab for Small Cell Lung Cancer Extensive Stage

• A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
  NCT07227597 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 52 locations
• DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
  NCT07545954 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
  NCT05703971 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations

Common questions

How many trials study Atezolizumab for Small Cell Lung Cancer Extensive Stage?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.